This is a bleeding disorder that runs in families. It happens because the blood doesn't clot properly, making it harder to stop bleeding. It's caused by a lack of a specific protein called factor VIII.
Every report comes from a Lived member, sent anonymously.
Have you tried Factor VIII for Hemophilia A?
Hemophilia A is an inherited bleeding disorder in which the blood is low in, or missing, a clotting protein called factor VIII (factor 8). Without enough factor VIII, a clot forms slowly and is weak, so bleeding lasts longer than it should. It is sometimes called classic hemophilia, and it is the most common type. The bleeding that matters most is often inside the body rather than from a cut. Blood can seep into joints, most often the knees, elbows and ankles, causing pain, swelling and stiffness, or into muscles. Other signs include easy bruising, nosebleeds that are hard to stop, and prolonged bleeding after dental work, surgery or injections. Repeated bleeding into the same joint can damage it over time, which is a central reason treatment focuses on preventing bleeds rather than only stopping them.
Hemophilia A is caused by a change in the gene that carries the instructions for factor VIII. That gene sits on the X chromosome. Males have one X chromosome, so a single changed copy is enough to cause hemophilia, and the condition mainly affects boys and men. Females have two X chromosomes and are usually carriers, but carriers are not always symptom-free: about 3 in 10 have factor VIII levels low enough to put them at risk of heavy bleeding, for example with periods, childbirth, surgery or dental work. A family history raises the likelihood, but it is not required. About one third of babies diagnosed with hemophilia have a new gene change not found in other relatives. Once someone has hemophilia A, bleeding episodes are set off by injury, surgery or procedures, and in more severe cases they can happen without any obvious cause. Aspirin and many anti-inflammatory pain relievers, such as ibuprofen (Advil, Motrin) and naproxen (Aleve), interfere with platelets, another part of clotting, and can make bleeding worse. A separate, rare condition called acquired hemophilia is not inherited. It happens when the immune system makes antibodies against factor VIII, usually later in life, and is managed differently.
Diagnosis starts with the bleeding history and family history, then blood tests. Screening clotting tests show whether blood clots normally, and a factor VIII activity test measures how much working factor VIII is present. Clinicians also check von Willebrand factor, a related clotting protein, because a shortage of it can lower factor VIII and mimic hemophilia A. The factor VIII result is given as a percentage of normal, and it sets the severity. Most people without hemophilia fall roughly between 50% and 150%. Below 1% is severe hemophilia, up to 5% is moderate, and levels above that but still below normal are mild. Severity predicts how someone bleeds. People with severe hemophilia are usually diagnosed in the first two years of life and, without preventive treatment, may have several bleeds a month that start on their own. People with moderate hemophilia bleed mainly after minor injuries. People with mild hemophilia may go years without trouble and are sometimes diagnosed only after unexpected bleeding with surgery or a tooth extraction. Genetic testing can identify the exact gene change. That helps confirm the diagnosis, test female relatives who may be carriers, and plan future pregnancies. Testing at-risk relatives early, and before a pregnancy where possible, lets care start before a serious bleed.
There is currently no cure in routine use, but treatment can prevent most bleeding and protect the joints. Care is usually led by a hemophilia treatment center, a specialist clinic whose team includes hematologists, nurses, physical therapists and genetic counselors. The long-standing approach is factor VIII replacement: a concentrate of factor VIII given by infusion into a vein. It can be given to treat a bleed, or on a regular schedule (prophylaxis) to keep factor levels high enough to prevent bleeds. Prophylaxis is the standard for severe hemophilia A and for people with milder disease who bleed often. Many families learn to give infusions at home, which allows early treatment at the first sign of a bleed. Emicizumab (Hemlibra) is a different kind of preventive medicine. It is an antibody that does the job of factor VIII in clotting, and it is injected under the skin once every one, two or four weeks rather than infused into a vein. It is approved from birth onward, including for people who have inhibitors. Two trade-offs matter. It makes some standard clotting tests read inaccurately, so labs and emergency teams need to know someone takes it. And combining it with high doses of one medicine used for breakthrough bleeds in people with inhibitors has caused serious clotting problems, so a treatment center gives each person a specific plan for treating bleeds while on it. Several newer non-factor injections, which work by rebalancing the clotting system, are approved for people 12 and older. For some people with mild hemophilia A, desmopressin, a hormone-like medicine that releases the body's own stored factor VIII, can cover minor bleeds or dental work. It only works for people whose testing shows a good response. Some people develop inhibitors, antibodies that neutralize infused factor VIII. This happens in roughly 15% to 20% of people with inherited hemophilia, most often early in treatment, and makes bleeds much harder to control. Options include bypassing medicines that help blood clot without factor VIII, emicizumab, and immune tolerance therapy, which uses frequent factor VIII doses over months to retrain the immune system to accept it. Physical therapy helps protect joints and restore movement after bleeds, and orthopedic surgery is sometimes needed for joints already damaged.
With modern preventive treatment, many people with hemophilia A go to school, work, travel and play sports, and life expectancy has risen. The day-to-day load depends on severity and treatment: a set schedule of infusions or injections, carrying treatment when traveling, and recognizing and treating bleeds early. Joint health is the main long-term concern. Even with good care, some people develop arthritis-like damage in joints that bled repeatedly, which can cause chronic pain and limit movement. Regular exercise that builds muscle around the joints helps, and the care team can advise which activities suit a person's bleeding risk. Activities with a high chance of head injury carry more risk, and helmets, seat belts and car seats matter more than usual. Routine care includes reviews at a hemophilia treatment center, usually every 6 to 12 months for moderate or severe hemophilia and every year or two for mild, with joint checks, a review of bleeds and a blood test for inhibitors. Before any surgery, dental extraction or other procedure, the treatment center plans extra clotting coverage. For pain relief, acetaminophen (Tylenol) is generally used instead of aspirin or anti-inflammatory medicines. As people with hemophilia live longer, ordinary age-related conditions, such as heart disease, become part of planning their care too.
Ask about testing if you or your child bruise easily, have nosebleeds or gum bleeding that is hard to stop, bleed heavily after dental work or surgery, or have a family history of hemophilia. Women in families with hemophilia should ask about carrier testing, ideally before pregnancy. For someone with hemophilia A, contact the treatment center right away for signs of a joint or muscle bleed: tingling, warmth, swelling, pain or stiffness in a joint, or a painful, swollen muscle. Early treatment limits damage. Also call if bleeds are becoming more frequent or treatment seems to work less well than before, which can signal an inhibitor. Treat any head injury as an emergency, even if the person seems fine, because bleeding inside the skull can start slowly. Give factor or other emergency treatment according to the treatment plan if possible, and go to an emergency department. Do the same for a severe or lasting headache, repeated vomiting, unusual sleepiness, confusion, a seizure, vision changes, or new weakness or numbness, and for belly pain or hip or groin pain with trouble standing or straightening the leg. Swelling in the neck or throat, or difficulty breathing or swallowing, needs 911. Tell emergency staff about the hemophilia and current treatment, including emicizumab, right away.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Hemophilia A is like, what's helped you, or ask the community a question.